Cart
sales@molnova.com
6-fluoro-3-(4-1,2,5,6-tetrahydropyridyl)indole
CAS No. 180161-14-2
6-fluoro-3-(4-1,2,5,6-tetrahydropyridyl)indole( 6-fluoro-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole )
Catalog No. M28396 CAS No. 180161-14-2
6-fluoro-3-(4-1,2,5,6-tetrahydropyridyl)indole is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 64 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 163 | In Stock |
|
| 50MG | 239 | In Stock |
|
| 100MG | 359 | In Stock |
|
| 200MG | 538 | In Stock |
|
| 500MG | 864 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-fluoro-3-(4-1,2,5,6-tetrahydropyridyl)indole
-
NoteResearch use only, not for human use.
-
Brief Description6-fluoro-3-(4-1,2,5,6-tetrahydropyridyl)indole is a chemical compound.
-
Description6-fluoro-3-(4-1,2,5,6-tetrahydropyridyl)indole is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms6-fluoro-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number180161-14-2
-
Formula Weight216.259
-
Molecular FormulaC13H13FN2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFc1ccc2c(c[nH]c2c1)C1=CCNCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Karakaya S, et al. The α-amylase and α-glucosidase inhibitory activities of the dichloromethane extracts and constituents of Ferulago bracteata roots. Pharm Biol. 2018 Dec;56(1):18-24.
molnova catalog
related products
-
Cyclic somatostatin ...
Cyclic somatostatin Acetate is a cyclic tetradecapeptide regulating many endocrine and nervous system functions.
-
Lupeol acetate
Lupeol acetate possesses antinociceptive, antifertility, and anti-inflammatory properties, the effect probably involves the opioid system, as indicated by the complete blockade of the opioid antagonist naloxone.
-
CL2A-SN-38 DCA 127...
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC).
